戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  hearing loss while being less prone to skin urticarial.
2 oidal anti-inflammatory drug (NSAID)-induced urticarial and angioedema reactions are among the most c
3 During treatment, minor allergic symptoms of urticarial and dyspnea were observed on two occasions, b
4 s and blisters (r = 0.985; P = .006) but not urticarial and erythematous lesions (r = 0.632; P = .23)
5                                   Vesicular, urticarial, and maculopapular eruptions and livedo, necr
6 o information is available for NSAID-induced urticarial/angioedema (NIUA), despite it being the most
7 ry syndrome coronavirus 2-vaccine-associated urticarial eruptions.
8 et autoinflammatory disease characterized by urticarial exanthema and monoclonal gammopathy accompani
9 d family members is characterized by chronic urticarial flares associated with extremely high plasma
10                         Chronic or recurrent urticarial lesions are common in both primary care and r
11                                              Urticarial lesions are observed in both cutaneous and sy
12 tified a new entity characterized by chronic urticarial lesions associated with a clinically blunted
13 rge family with dominantly inherited chronic urticarial lesions associated with hypercytokinemia.
14 (approximately 10%) of patients with chronic urticarial lesions have urticarial vasculitis.
15 ntibody to IgE receptor or IgE itself causes urticarial lesions in 30% of these patients.
16  circulating BP180 NC16A IgE antibodies with urticarial or erythematous lesions was observed (r = 0.4
17 teria (no primary skin lesions), eczematous, urticarial, papular, and/or nodular skin lesions were se
18 r tested for the use in various allergic and urticarial pathologies, by providing an overview on thei
19 r), and most (n = 18, 64%) presented with an urticarial phenotype.
20 t common adverse events of these grades were urticarial rash (grade 3, equally common in both groups)
21 ient with two obligate criteria: a recurrent urticarial rash and a monoclonal IgM gammopathy, and two
22 isorders in patients presenting with chronic urticarial rash and discuss their clinical picture and m
23 ler's syndrome is characterized by recurrent urticarial rash and monoclonal gammopathy, associated wi
24 linically significant toxicity except for an urticarial rash in one patient just after the second inf
25                                 Cold-induced urticarial rash is among the main clinical features.
26   Schnitzler syndrome is characterized by an urticarial rash, a monoclonal gammopathy, and clinical,
27 t a four-generation family with cold-induced urticarial rash, arthralgia, chills, headache and malais
28 XII-W268R carriers experience cold-inducible urticarial rash, arthralgia, fever, and fatigue.
29 lammatory disease is characterized by fever, urticarial rash, aseptic meningitis, deforming arthropat
30  shares several clinical symptoms, including urticarial rash, fever episodes, arthralgia, and bone an
31 nostic criteria for Schnitzler syndrome with urticarial rash, fever, arthralgia, and bone pain; 47% r
32 iated cytopenias in all patients, as well as urticarial rash, oral ulceration, lymphopenia, and perip
33                               Apart from the urticarial rash, patients are suffering from a variety o
34 veral less common diseases that present with urticarial rash, such as urticarial vasculitis and autoi
35 and treating patients with chronic recurrent urticarial rash.
36 NLRP3 and minimal prevalence of cold-induced urticarial rash.
37 reat condition characterized by long-lasting urticarial rashes and histopathologic findings of leukoc
38 meat in 12 subjects with a history of severe urticarial reactions 3 to 6 hours after eating beef, por
39 gle dose of Na-ASP-2 resulted in generalized urticarial reactions in several volunteers.
40                            As we observed an urticarial response, a potential role for histamine was
41      All participants exhibited an immediate urticarial response, both wheal and flare correlating wi
42 Histamine release after ALA-PDT mirrored the urticarial response, levels peaking within 30 minutes an
43 ngitis, uveitis, sensorineural hearing loss, urticarial skin rash, and a characteristic deforming art
44 kin biopsies from a patient who developed an urticarial skin reaction.
45                                              Urticarial skin reactions are one of the most frequent p
46                                              Urticarial skin reactions following MOv18 IgE treatment
47 allergic response parameters associated with urticarial skin reactions in MOv18 IgE-treated patients.
48 -treated patients, 62.5% developed transient urticarial skin reactions, with onset during the first i
49 he most common adverse event being transient urticarial skin reactions.
50                            Familial forms of urticarial syndromes are rare and can be encountered in
51 c - as well as the differential diagnosis of urticarial syndromes in the pediatric population.
52 hese patients have varied from eczematous or urticarial to papular or nodular skin lesions.
53                                              Urticarial vasculitis (UV) is a difficult-to-treat condi
54                                              Urticarial vasculitis (UV) is a rare cutaneous vasculiti
55 s that present with urticarial rash, such as urticarial vasculitis and autoinflammatory disorders.
56              Although some cases are benign, urticarial vasculitis by itself can cause significant mo
57 eases such as autoinflammatory syndromes and urticarial vasculitis in patients with recurrent wheals
58        Successful diagnosis and treatment of urticarial vasculitis requires careful assessment over t
59 emic lupus erythematosus, hypocomplementemic urticarial vasculitis syndrome, Sjogren's syndrome, and
60 atients with chronic urticarial lesions have urticarial vasculitis.
61                     Back on the diving boat, urticarial was noticed.